This study trials a prototype artificial pancreas system that consists of a Roche insulin
pump, a Dexcom continuous glucose monitor (CGM), and an experiential MMPPC (multiple model
probabilistic predictive control) algorithm housed on an android cell phone. The system doses
insulin based on CGM sensor glucose levels and the experimental algorithm.
The aim of this clinical study is to determine the efficacy of the MMPPC controller in
adolescents and adults with type 1 diabetes in a hotel setting.